SCHEMBL18052105

SCHEMBL18052105

CN(C(=O)NC1CCCCC1)C1CC1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 1/20 0.52
PKM P14618 1/20 0.51
EPHX1 P07099 6/20 0.50
RAB9A P51151 3/20 0.50
NPC1 O15118 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAPT P10636 1/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP3A4 P08684 1/20 0.50
EPHX2 P34913 1/20 0.50
ATM Q13315 1/20 0.47
HPGD P15428 1/20 0.46
ADRA2A P08913 1/20 0.45
PDE4A P27815 1/20 0.45
ADRA1A P35348 1/20 0.45
NPSR1 Q6W5P4 1/20 0.43
NPY5R Q15761 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL679618 0.96 CCR5 (0.52) CCR5PKMEPHX1RAB9ANPC1
SCHEMBL7022369 0.94 CCR5 (0.50) CCR5PKMEPHX1RAB9ANPC1
SCHEMBL7021364 0.92 CCR5 (0.48) CCR5PKMEPHX1RAB9ANPC1
SCHEMBL7024470 0.90 NPY5R (0.49) CCR5NPY5R
SCHEMBL18629454 0.88 CCR5 (0.47) CCR5PKMEPHX1RAB9ANPC1
SCHEMBL2869853 0.81 EPHX1 (0.56) PKMEPHX1RAB9ANPC1SMN1; SMN2
SCHEMBL135838 0.81 EPHX1 (0.56) PKMEPHX1RAB9ANPC1SMN1; SMN2
SCHEMBL11608613 0.81 EPHX1 (0.56) PKMEPHX1RAB9ANPC1SMN1; SMN2
SCHEMBL9451038 0.81 EPHX1 (0.56) PKMEPHX1RAB9ANPC1SMN1; SMN2
Hydrochloric Acid SCHEMBL3720424 0.79 PKM (0.54) PKMEPHX1RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3141252-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Inc. (US) 2017-03-15 EP disclosed
EP-2442809-B1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMA (US) 2016-08-31 EP disclosed